RotaShield: The ill-fated Rhesus - Human reassortant rotavirus vaccine. A history of the first rotavirus vaccine and its withdrawal from the market

Pediatric Annals

Volumn 35, Issue 1, 2006, Pages 44-50

  Matson, David O ^a,b,c  

^a Department of Pediatrics ^*  (United States)

^b CENTER FOR PEDIATRIC RESEARCH   (United States)

^c Center for Pediatric Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; ROTAVIRUS VACCINE;

CLINICAL TRIAL; DRUG DESIGN; HUMAN; INTUSSUSCEPTION; LICENSING; NONHUMAN; REVIEW; ROTAVIRUS; SEROTYPE; VIRUS INFECTION;

EID: 31344481581     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20060101-13     Document Type: Review

References (38)

1. Jenner EI. Inquiry into the causes and effects of the variolæ vaccinæ, or cow-pox. 1798. In: Eliot C, ed. The Three Original Publications on Vaccination Against Smallpox. New York, NY: P.F. Collier & Son; 1909.
2. Withdrawal of Rotavirus Vaccine, Live, Oral, Tetravalent (RotaShield) Food and Drug Administration. 2002. Available at: http://www. fda.gov/cber/recalls/rota101599.htm. Accessed November 29, 2005.
3. Kapikian AZ, Flores J, Hoshino Y, et al. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a " Jennerian" approach to vaccination. J Infect Dis. 1986;153(5):815-822.
4. Kapikian AZ, Wyatt RG, Greenberg HB, et al. Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis. 1980;2(3):459-469.
5. Flores J, Perez-Schael I, Gonzalez M, et al. Protection against severe rotavirus diarrhaea by rhesus rotavirus vaccine in Venezuelan infants. Lancet. 1987;1(8538):882-884.
6. Matson DO, Estes MK, Burns JW, et al. Serotype variation of human group A rotaviruses in two regions of the USA. J Infect Dis. 1990;162(3):605-614.
7. Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadravalent vaccine in infants and young children in Venezuela. N Engl J Med. 1997;337(17):1181-1187.
8. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines-report of the National Multicenter Trial, United States Rotavirus Vaccine Efficacy Group. Pediatrics. 1996;97(1):7-13.
9. Bernstein DI, Glass RI, Rodgers G, et al. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. children. U.S. Rotavirus Vaccine Efficacy Group. JAMA. 1995;273(15):1191-1196.
10. Santosham M, Moulton LH, Reid R, et al. Efficacy and safety of high-dose rhesus-human re-assortant rotavirus vaccine in Native American populations. J Pediatr. 1997;131(4):632-638.
11. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet. 1997;350(9086):1205- 1209.
12. Rennels MB, Parashar UD, Holman RC, et al. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr Infect Dis J. 1998;17(10):924-925.
13. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-2):1-20.
14. Smith PJ, Schwartz B, Mokdad A, et al. The first oral rotavirus vaccine, 1998-1999: estimates of uptake from the National Immunization Survey. Public Health Rep. 2003; 118(2):134-143.
15. Suspension of rotavirus vaccine after reports of intussusception - United States, 1999. MMWR Morb Mortal Wkly Rep. 2004; 53(34):786-789.
16. Intussusception among recipients of rotavirus vaccine-US, 1998-1999. Ann Pharmacother. 1999;33(9):1020-1021.
17. Chang HG, Glass RI, Smith PF, et al. Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J. 2003;22(9):808-814.
18. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344(8):564-572.
19. Kramarz P, France EK, DeStefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J. 2001;20(4):410-416.
20. Simonsen L, Morens D, Elixhauser A, et al. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet. 2001;358(9289):1224-1229.
21. Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis. 2005;192(Suppl 1): S36-S43.
22. Murphy BR, Morens DM, Simonsen L, et al. Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis. 2003;187(8):1301-1308.
23. Chang HG, Smith PF, Ackelsberg J, Morse DL, Glass RI. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state. Pediatrics. 2001;108(1):54-60.
24. Verstraeten T, Baughman AL, Cadwell B, et al. Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol. 2001;154(11):1006-1012.
25. Haber P, Chen RT, Zanardi LR, et al. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone? Pediatrics. 2004; 113(4): e353-e359.
26. Chang EJ, Zangwill KM, Lee H, Ward JI. Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J. 2002;21(2):97-102.
27. Velazquez FR, Luna G, Cedillo R, Torres J, Munoz O. Natural rotavirus infection is not associated to intussusception in Mexican children. Pediatr Infect Dis J. 2004;23(10 Suppl): S173-S178.
28. Andrews N, Miller E, Waight P, et al. Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom. Eur J Epidemiol. 2001;17(8):701-706.
29. Li ST, Davis RL, Weiss NS. Intussusception and oral poliovirus vaccination: is there an association? Am J Epidemiol. 2004;160(6):576-581.
30. Pang LC. Intussusception revisited: clinico-pathologic analysis of 261 cases, with emphasis on pathogenesis. South Med J. 1989; 82(2):215-228.
31. Cunnane SC, Bloom SR. Intussusception in the Syrian golden hamster. Br J Nutr. 1990; 63(2):231-237.
32. Ein SH, Alton D, Palder SB, Shandling B, Stringer D. Intussusception in the 1990s: has 25 years made a difference? Pediatr Surg Int. 1997;12(5-6):374-376.
33. Ein SH, Stephens CA. Intussusception: 354 cases in 10 years. J Pediatr Surg. 1971;6(1):16-27.
34. Peter G, Myers MG, National Vaccine Advisory Committee, National Vaccine Program Office. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 2002;110(6):e67-e72.
35. Moser CA, Dolfi DV, Di Vietro ML, et al. Hypertrophy, hyperplasia, and infectious virus in gut-associated lymphoid tissue of mice after oral inoculation with simian-human or bovine-human reassortant rotaviruses. J Infect Dis. 2001;183(7):1108-1111.
36. Uhnoo I, Riepenhoff-Talty M, Dharakul T, et al. Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus. J Virol. 1990;64(1):361-368.
37. Iwamoto M, Saari TN, McMahon SR, et al. A survey of pediatricians on the reintroduction of a rotavirus vaccine. Pediatrics. 2003;112(1 pt 1):e6-el0.
38. Sansom SL, Barker L, Corso PS, Brown C, Deuson R. Rotavirus vaccine and intussusception: how much risk will parents in the United States accept to obtain vaccine benefits? Am J Epidemiol. 2001;154(11):1077-1085.